2015
DOI: 10.1016/j.tvjl.2015.03.029
|View full text |Cite
|
Sign up to set email alerts
|

Advances in the understanding of the clinically relevant genetic pathways and molecular aspects of canine mammary tumours. Part 2: Invasion, angiogenesis, metastasis and therapy

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
21
0

Year Published

2015
2015
2023
2023

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 11 publications
(21 citation statements)
references
References 108 publications
0
21
0
Order By: Relevance
“…The anatomy of the normal mammary gland is similar in dogs and women. The alveoli and ducts of the mammary gland consist of luminal epithelial cells lined by myoepithelial cells and are separated from the surrounding connective tissue by the basement membrane (Liu et al, 2014;Santos and Matos, 2015). In both species tumor formation is seen as a dynamic process starting from benign hyperplastic lesions that can evolve into a carcinoma in situ.…”
Section: Canine Mammary Tumors As a Model For Human Breast Cancermentioning
confidence: 99%
See 1 more Smart Citation
“…The anatomy of the normal mammary gland is similar in dogs and women. The alveoli and ducts of the mammary gland consist of luminal epithelial cells lined by myoepithelial cells and are separated from the surrounding connective tissue by the basement membrane (Liu et al, 2014;Santos and Matos, 2015). In both species tumor formation is seen as a dynamic process starting from benign hyperplastic lesions that can evolve into a carcinoma in situ.…”
Section: Canine Mammary Tumors As a Model For Human Breast Cancermentioning
confidence: 99%
“…In a further step, these tumors can become invasive, which is marked by the disruption of the basement membrane and potential seeding of metastases (Gilbertson et al, 1983;Burstein et al, 2004;Simpson et al, 2005;Sorenmo et al, 2009). On a molecular level, many of the key alterations in human breast cancer are faithfully recapitulated in CMTs, including germline mutations in BRCA1, BRCA2, and TP53 that are associated with an enhanced risk of hereditary cancer in humans (Liu et al, 2014;Matos and Santos, 2015;Santos and Matos, 2015;Schiffman and Breen, 2015). And finally, besides clinical factors such as tumor size, lymph node involvement, and clinical stage, the prognostic value of histo-pathological aspects such as tumor type and grade, and molecular subtypes (luminal A, luminal B, HER2-enriched, and basal-like) is conserved between canine and human breast cancer (Rivera et al, 2009;Queiroga et al, 2011b;Sleeckx et al, 2011;Lahkhani et al, 2012;Rasotto et al, 2012Rasotto et al, , 2017Im et al, 2013;Pena et al, 2013;Nguyen et al, 2017).…”
Section: Canine Mammary Tumors As a Model For Human Breast Cancermentioning
confidence: 99%
“…Retrospective studies exploring cytotoxic agents are mostly restricted to a limited number of dogs, included in the respective studies. Complex prospectivly conducted studies evaluating experimental therapeutic protocols are practically missing [32]. However, the establishment of non-invasive therapeutic approaches for mammary carcinomas is currently addressed in various ways.…”
Section: Discussionmentioning
confidence: 99%
“…E‐cadherin (codified by CHD1 ) is a cell adhesion molecule expressed in epithelial tissues that promote cell adhesion in adjacent cells . It has shown that loss of its cytoplasm membrane expression is associated with lymph node metastasis, high invasiveness, recurrence and poor prognostic . Progression to metastasis is a multistep process that involves the acquisition of invasive attributes .…”
Section: Discussionmentioning
confidence: 99%
“…13 -15 Survival of dogs suffering from CMT is mainly dependent on the occurrence of metastases. 13,14 In addition to the established histological classifications and clinical staging, many new molecular markers have been evaluated for their predictive value in terms of metastatic action and reduced survival, such as steroid receptors, markers of cell adhesion or proliferation. 16 However, the description of metastatic potential in CMT is still based on histological, clinical and radiographic examination, which can only report dissemination of tumour cells that already took place.…”
Section: Introductionmentioning
confidence: 99%